Contact: Kate Husher or Erica Boardman
+44 (0)20 7970 6030
press@icr.ac.uk

Screening Leads to Substantial Reduction in Breast Cancer Deaths

The introduction of a National Health Service breast screening program, along with improvements in treatment for breast cancer, led to a 21 percent reduction in breast cancer deaths in England and Wales between 1990 and 1998, finds a study in this week's British Medical Journal.

Using national data on breast cancer deaths for 1971-1989, Roger Blanks, PhD, and colleagues were able to predict the number of deaths for 1990-1998. The effect of screening and other factors on breast cancer deaths during this period was then estimated by comparing observed deaths with those predicted among women aged from 50-54 and from 75-79 years, the effect of screening being restricted to certain age-groups.

They found that in 1998, estimated deaths from breast cancer were 21 percent below that predicted in the absence of screening or other effects in women aged 55-69. Of this fall, 6 percent to 7 percent was as a direct effect of screening, and equates to 320 prevented deaths. Other factors, such as improvements in treatment and presentation of cancers at an earlier stage, also play major roles in the substantial reduction in deaths from breast cancer.

Despite several limitations in projecting deaths into future years, the authors are confident that further effects from screening, together with improved treatments, should result in yet further reductions in breast cancer deaths, particularly for women aged 55-69, over the next 10 years.

Contact: Kate Husher or Erica Boardman at Press Office, The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, Tel: ++44 (0)20 7970 6030 Mobile: 07788 427 856, Fax: ++44 ( 0)20 7970 6018 E-mail: press@icr.ac.uk.

(Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: Comparison of observed with predicted mortality. British Medical Journal, Volume 321, pp. 665-669)

###

For further information about the British Medical Journal or to obtain a copy of the article, please contact Public Affairs Division, British Medical Association, BMA House, Tavistock Square, London WC1H 9JP, Tel: 020 7383 6254 or e-mail: pressoffice@bma.org.uk. After 6 p.m. and on weekends telephone: +44 (0)208 241 6386 / +44 (0)208 997 3653/+44 (0)208 674 6294 / +44 (0)1525 379792 / +44 (0)208 651 5130.